Treatment rationale and protocol design: an investigator-initiated phase II study of combination treatment of nivolumab and TM5614, a PAI-1 inhibitor for previously treated patients with non-small cell lung cancer - Masuda, Takeshi; Hirata, Taizo; Sakamoto, Tomohiro; Tsubata, Yukari; Ichihara, Eiki; Kozuki, Toshiyuki; Shoda, Hiroyasu; Motonaga, Masanori; Yoshida, Takako; Fukutani, Miki; Tsuji-Takayama, Kazue; Tamura, Atsushi; et al. (Journal of Thoracic Disease; Vol 16, No 5 (May 31, 2024): Journal of Thoracic Disease, 2024)